Annual Accounts Payable
$2.99 M
-$607.00 K-16.89%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual accounts payable is $2.99 million, with the most recent change of -$607.00 thousand (-16.89%) on December 31, 2023.
- During the last 3 years, BOLT annual accounts payable has risen by +$1.39 million (+86.92%).
- BOLT annual accounts payable is now -16.89% below its all-time high of $3.59 million, reached on December 31, 2022.
Performance
BOLT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.48 M
-$1.15 M-43.59%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly accounts payable is $1.48 million, with the most recent change of -$1.15 million (-43.59%) on September 30, 2024.
- Over the past year, BOLT quarterly accounts payable has dropped by -$1.15 million (-43.59%).
- BOLT quarterly accounts payable is now -71.25% below its all-time high of $5.16 million, reached on September 30, 2021.
Performance
BOLT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BOLT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.9% | -43.6% |
| 3 y3 years | +86.9% | -43.6% |
| 5 y5 years | +234.9% | -43.6% |
BOLT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.9% | at low | -66.7% | at low |
| 5 y | 5-year | -16.9% | +86.9% | -71.3% | at low |
| alltime | all time | -16.9% | +234.9% | -71.3% | at low |
Bolt Biotherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.48 M(-43.6%) |
| Jun 2024 | - | $2.63 M(+18.4%) |
| Mar 2024 | - | $2.22 M(-25.7%) |
| Dec 2023 | $2.99 M(-16.9%) | $2.99 M(-18.9%) |
| Sep 2023 | - | $3.68 M(+7.2%) |
| Jun 2023 | - | $3.44 M(+87.2%) |
| Mar 2023 | - | $1.83 M(-48.9%) |
| Dec 2022 | $3.59 M | $3.59 M(-6.1%) |
| Sep 2022 | - | $3.83 M(+13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $3.36 M(-24.4%) |
| Mar 2022 | - | $4.45 M(+24.4%) |
| Dec 2021 | $3.57 M(+123.7%) | $3.57 M(-30.7%) |
| Sep 2021 | - | $5.16 M(+219.4%) |
| Jun 2021 | - | $1.61 M(-44.1%) |
| Mar 2021 | - | $2.89 M(+80.7%) |
| Dec 2020 | $1.60 M(-23.7%) | $1.60 M(-53.0%) |
| Sep 2020 | - | $3.40 M(+62.2%) |
| Dec 2019 | $2.10 M(+134.9%) | $2.10 M |
| Dec 2018 | $892.00 K | - |
FAQ
- What is Bolt Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual accounts payable year-on-year change?
- What is Bolt Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly accounts payable year-on-year change?
What is Bolt Biotherapeutics annual accounts payable?
The current annual accounts payable of BOLT is $2.99 M
What is the all time high annual accounts payable for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual accounts payable is $3.59 M
What is Bolt Biotherapeutics annual accounts payable year-on-year change?
Over the past year, BOLT annual accounts payable has changed by -$607.00 K (-16.89%)
What is Bolt Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of BOLT is $1.48 M
What is the all time high quarterly accounts payable for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly accounts payable is $5.16 M
What is Bolt Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, BOLT quarterly accounts payable has changed by -$1.15 M (-43.59%)